jump to content jump to footer

Medical University of Innsbruck: Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery

This study [1] aimed to examine tissue changes in patients with head and neck squamous cell carcinoma (HNSCC) after primary radiochemotherapy (RCT) using radiomic feature analysis. Patients with locally advanced HNSCC frequently require primary RCT. Despite intensity modulation, the desired radiation-induced effects observed in HNSCC may also be observed as side effects in healthy tissue, e.g., the sternocleidomastoid muscle (SCM). The optimal time window for salvage surgery, a treatment often considered after primary RCT, is generally believed to be between 6 to 12 weeks post-RCT. This timeframe is largely determined by clinical studies focusing on surgical complications, rather than directly exploring radiation's impact on the SCM.

This study is the first to explore short-term RCT-induced skeletal muscle alterations after RCT in HNSCC patients applying radiomics, a data-driven approach aiming at extracting and processing quantitative data to analyze image-based information

Using the mint Lesion™ Radiomics module, researchers analyzed the CT scans of 98 HNSCC patients, focusing on three key radiomic parameters:  volume, mean positivity of pixels (MPP), and uniformity.

The study revealed a significant reduction in volume after primary RCT. Specifically, the SCM volume decreased from 9.0 to 8.4 mL, and the paravertebral musculature (PVM) volume dropped from 96.5 to 91.9 mL. This observed decrease was unexpected, as an increase was anticipated due to inflammation and edema in the SCM directly affected by irradiation. Moreover, a significant drop in PVM volumes was noted, which was primarily influenced by chemotherapy and not irradiation.

It was determined that these volume changes were unlikely to be caused solely by irradiation, chemotherapy, or their combination. In the course of the study, significant reductions were observed in both BMI (from 23.9 to 21.0 kg/m²) and serum protein levels (from 7.4 to 6.6 mg/%). These observed reductions were found to be closely correlated with the changes in volume. Once the results were adjusted for the variations in BMI, the volume changes for SCM and PVM post-treatment were rendered insignificant.

The findings of this study underscore the paramount importance of closely monitoring and optimizing patients' nutrition before, during, and after undergoing primary RCT. Previous studies have linked lower serum protein levels and BMI to increased complication rates in patients who later undergo salvage surgery. When accounting for changes in BMI, no significant alterations in muscle volume or other radiomic features indicative of tissue fibrosis were found. Thus, this study supports the existing clinical consensus that the best period for salvage surgery following RCT lies between 6 to 12 weeks.

Read the original publication here.

[1] Santer, M.; Riechelmann, H.; Hofauer, B.; Schmutzhard, J.; Freysinger, W.; Runge, A.; Gottfried, T.M.; Zelger, P.; Widmann, G.; Kranebitter, H.; et al. Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery—A Pilot Study. Cancers 2023

Onur Özek from Mint Medical discusses the challenges, requirements, and future of lung cancer screening in Germany in an interview with RadMag.
In the latest RadMag Special Edition, Onur Özek discusses structured reporting, AI integration, second-reader workflows, interoperability, and the importance of end-to-end workflow management for lung cancer.
RadMag Special Edition: Onur Özek on the Challenges of Lung Cancer Screening in Germany
With the nationwide rollout of Germany’s lung cancer screening, radiology providers are facing new challenges. Structured reporting, mandatory second…
Read more
Integrated prostate cancer workflow connecting radiology, urology, and pathology through structured reporting, MRI-guided biopsy, longitudinal follow-up, and AI-supported analysis.
mint Lesion supports an end-to-end prostate cancer workflow by connecting radiology, urology, and pathology within a unified digital environment. The platform enables structured mpMRI reporting, MRI/ultrasound fusion biopsy workflows, FHIR-based interoperability, active surveillance, and AI-supported quantification of metastatic disease.
Be Central to the Insight: A Structured, Data-Driven Approach to the End-to-End Prostate Pathway
Digital Integration for Multidisciplinary Teams  In the complex journey of prostate cancer diagnostics, the data contributed by every department is…
Read more
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026
Presentation of a research poster by Memorial Sloan Kettering Cancer Center on the use of mint Lesion for structured tumor response assessments and clinical research workflows.
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Read more
scroll-top